Mode
Text Size
Log in / Sign up

Transcriptomic analysis of DLPFC identifies five-gene model for schizophrenia diagnosis in small cohortFive Genes Could Help Diagnose Schizophrenia Sooner

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret the five-gene diagnostic model as preliminary evidence due to small sample size and observational design.

This cohort study investigated gene expression in the dorsolateral prefrontal cortex among 9 SCZ patients and 14 controls using single-cell and bulk RNA-seq data. The analysis leveraged existing datasets GSE174407 and GSE107638 to examine cell type-specific alterations in fatty acid metabolism-related genes. Intervention or exposure details were not reported.

Specific neuronal cell subtypes, including CUX2+ NeuN and OPRM1+ NeuN, were significantly upregulated in schizophrenia cases. Five key genes associated with pathogenesis were identified: ACAA1, ACAT2, ACSS1, PSME1, and S100A10. The diagnostic model demonstrated an area under the ROC curve of 0.856 in the training cohort and 0.779 in the validation cohort.

Safety and tolerability data were not reported for this observational analysis. The study noted significant differential expression of related genes in schizophrenia mice with p < 0.001 and significant negative correlations with inflammatory genes at p < 0.05. Although the practice relevance suggests translational potential for a five-gene diagnostic model, the small sample size and observational nature require cautious interpretation before clinical adoption. Limitations were not explicitly reported in the source data, but the sample size remains a constraint.

  • Scientists found five genes linked to brain changes in schizophrenia.
  • This could help doctors identify the condition earlier in life.
  • The test is still in research and not ready for clinics.

Researchers found a specific set of genes that might help doctors spot schizophrenia earlier.

Imagine waiting months for answers about your mental health. You feel confused, and so does your family.

Schizophrenia is a serious brain condition. It affects how people think and feel.

Doctors often wait for clear symptoms before diagnosing. This delay can make treatment harder to start.

Early help is key for better long-term results.

Why diagnosis is so hard

For years, diagnosis relied mostly on behavior. Doctors looked at what patients said and did.

But biology tells a different story. The brain changes before symptoms become obvious.

This study looks inside the brain cells. It focuses on how cells use energy.

The hidden biological clue

Think of brain cells like cars on a highway. They need fuel to run.

In schizophrenia, the fuel system gets clogged. This study found specific genes linked to this problem.

These genes control how fats are burned for energy.

Scientists compared brain tissue from patients and healthy people. They also tested mice with similar symptoms.

The team studied nine patients and fourteen controls. They used advanced computer tools to read genetic data.

What the numbers mean

Five genes stood out as key markers. These genes were active in specific brain cells.

The new model predicted schizophrenia with high accuracy. It worked well in both training and testing groups.

The results suggest these genes are involved in inflammation.

This doesn’t mean this treatment is available yet.

Experts say this is a major step forward. It moves us from guessing to measuring.

This helps us understand the disease better. It opens doors for new tests in the future.

You cannot take this test at a doctor’s office today. It needs more work before approval.

Talk to your doctor if you have concerns. Do not try to self-diagnose based on genes.

The human group was small. Most data came from lab samples.

We need to see if this works for everyone. Different groups might have different genetic patterns.

Scientists need to test this in larger groups. They must prove it works for everyone.

Approval takes time to ensure safety and accuracy.

This research brings us closer to a blood test. But patience is still required for real-world use.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study integrates single-cell and bulk RNA-seq to investigate cell type-specific alterations in fatty acid metabolism-related genes in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia (SCZ) patients and to evaluate their potential as diagnostic biomarkers.MethodsIntegrating single-cell sequencing data (9 SCZ patients and 14 controls) and Bulk RNA-seq data (GSE174407, GSE107638), cell subpopulation identification and annotation were performed using Seurat. Key genes were identified by integrating differential gene screening, transcriptional regulatory network construction (SCENIC), pseudotime analysis (Monocle 2), and functional enrichment. A multi-gene diagnostic model was established using LASSO regression. Model performance was validated using ROC curves, nomograms, and immune cell correlation analysis. Finally, an MK-801-induced mouse SCZ model was used to validate the expression of key genes via qPCR.ResultsThe study found that specific neuronal cell subtypes (e.g., CUX2+ NeuN and OPRM1+ NeuN) were significantly upregulated in SCZ, and the differentially expressed genes (DEGs) in these cells (e.g., HSP90AA1, HSPA1A, PTPRO) were significantly enriched in fatty acid metabolism pathways. Further regression analysis identified five key genes associated with SCZ pathogenesis (ACAA1, ACAT2, ACSS1, PSME1, and S100A10). Subsequent analysis indicated that these genes not only participate in inflammatory responses in neuronal cells, showing significant negative correlations with inflammatory genes (p < 0.05), but are also closely related to disease diagnosis and prognosis. A diagnostic model and nomogram for SCZ were constructed based on these genes. The area under the ROC curve (AUC) for the model was 0.856 in the training cohort and 0.779 in the validation cohort, indicating reliable predictive performance for SCZ diagnosis. The SCZ risk predicted by the nomogram closely matched the actual risk. Furthermore, the Decision Curve Analysis (DCA) curve showed that the central gene curve was above the gray line, indicating a significant net benefit from using the nomogram to predict SCZ risk. Finally, significant differential expression of related genes was also found in SCZ mice (p < 0.001).ConclusionThis study reveals cell type-specific dysregulation of fatty acid metabolism in SCZ and provides a robust five-gene diagnostic model with translational potential.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.